Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Transplant Proc. 2011 Dec;43(10):3892–3898. doi: 10.1016/j.transproceed.2011.09.072

Table 2.

AUC Parameter measured Time of Observation for FEV1 slope Correlation (r) 95% CI p value
BAL CD8 GranzymeB frequency 1–6 month −.63 −.83 to−.29 0.001
BAL CD8 GranzymeB frequency 1–9 month −.61 −.82 to−.26 .001
BAL CD8 GranzymeB frequency 1–12 month −.52 −.77 to−.13 .01
BAL CD8 Granzyme B Absolute Cell count 1–9 month −.68 −.86 ti−.29 .0003
BAL CD8 GranzymeB frequency 1–18 month −.43 −.73 to 0 .05
BAL CD8 GranzymeB frequency 9–18 month −.13 −.53 to .31 .5
BAL CD8 GranzymeB frequency 1 month- last data point −.34 −.66 to .09 .1
BAL CD8 GranzymeB frequency 9 month- last data point −.11 −.5 to .32 .6
PBMC CD8 Granzyme B frequency 1–12 month −.11 −.32 to .50 .6

Correlation of 1 year Granzyme B exposure measured in the BAL or pbmc with lung function trends over different time intervals post transplant.